The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Balestier, startups are often financed by Ben Franklin Technology Partners of Southeastern Pennsylvania. The meaningful sponsors for the fund in investment in the same round are Synergy Ventures, Sofinnova Partners, French sovereign investment bank.
The high activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
We can highlight the next thriving fund investment areas, such as Medical Device, Emergency Medicine. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Cagent Vascular, LimFlow SA. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
Related Funds
| Fund Name | Location |
| BRJ Investments, LLC | - |
| Captii Ventures | Malaysia, Selangor, Selangor |
| CCEIF Fund | Beijing, Beijing, China |
| France 2i | - |
| Hoche Partners | France, Ile-de-France, Paris |
| Micheli Associati | Italy, Lombardy, Milan |
| Shinhan Bank | Seoul, Seoul-t'ukpyolsi, South Korea |
| The Business Engineering, Science & Technology Discoveries Fund of Toronto | Canada, Ontario, Toronto |
| The Eisner Foundation | Beverly Hills, California, United States |
| The Greenspun Corporation | Henderson, Nevada, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cagent Vascular | $11M | 12 Jul 2018 | Radnor Township, Pennsylvania, United States | ||
LimFlow SA | $31M | 16 Apr 2018 | Ile-de-France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cagent Vascular | $11M | 12 Jul 2018 | Radnor Township, Pennsylvania, United States | ||
LimFlow SA | $31M | 16 Apr 2018 | Ile-de-France |
